New drug could halt Alzheimer’s disease
The Telegrapharrow_outwardRoche to investigate whether new drug can delay or prevent Alzheimer’s disease
Reutersarrow_outwardRoche’s Next-Gen Alzheimer’s Antibody Clears or Reduces Amyloid Plaques in Seven Months
BioSpacearrow_outward‘Game-changing’: New drug could halt Alzheimer’s - dailytelegraph.com.au
Dailytelegraph.com.auarrow_outwardNew 'game-changing' wonder-drug could halt Alzheimer's progression - lbc.co.uk
Lbc.co.ukarrow_outwardPromising new drug offers hope for Alzheimer’s patients - The Times
The Timesarrow_outwardNovel Anti-Amyloid Drug Aims to Outperform Current Standards - MedPage Today
MedPage Todayarrow_outwardNew Insights on Alzheimer Disease Treatments and Diagnostic Tools: Trontinemab and the Elecsys pTau217 - Psychiatric Times
Psychiatric Timesarrow_outwardRoche Bets Big On Alzheimer’s Prevention With New Trial As Duchenne Drug Setback Looms - MSN
MSNarrow_outwardRoche Unveils Alzheimer’s Phase III Plan And Preclinical Study - insights.citeline.com
Insights.citeline.comarrow_outwardRoche to Launch Pivotal Trials of Anti-Amyloid Drug Trontinemab in Early, Preclinical Alzheimer’s - Precision Medicine Online
Precision Medicine Onlinearrow_outwardRoche expands phase 3 plans for Alzheimer's drug - pharmaphorum
Pharmaphorumarrow_outwardRoche sets sights on Phase III with promising trontinemab data - The Pharma Letter
The Pharma Letterarrow_outwardRoche Advances Alzheimer’s Drug and Blood Test at AAIC - Technology Networks
Technology Networksarrow_outwardRoche's Trontinemab: A Game-Changer in Alzheimer's Disease Treatment and Diagnostics - AInvest
AInvestarrow_outwardGenentech and Roche Present New Insights in Alzheimer's Disease - GuruFocus
GuruFocusarrow_outwardRoche presents new insights in Alzheimer’s disease research - GlobeNewswire
GlobeNewswirearrow_outwardRoche to investigate if drug can prevent Alzheimer's - Dungog Chronicle
Dungog Chroniclearrow_outwardRoche Bets Big On Alzheimer’s Prevention With New Trial As Duchenne Drug Setback Looms - Asianet Newsable
Asianet Newsablearrow_outwardRoche to Test New Alzheimer’s Drug - Famagusta Gazette
Famagusta Gazettearrow_outwardRoche launches late-stage trial to prevent Alzheimer’s disease symptoms - The Eastern Herald
The Eastern Heraldarrow_outwardRoche Ventures Further into Alzheimer's Research: Trontinemab in Focus - Devdiscourse
Devdiscoursearrow_outwardRoche to investigate whether new drug can delay or prevent Alzheimer’s disease - PharmaLive
PharmaLivearrow_outwardRoche to test if new drug can prevent Alzheimer’s disease, Bloomberg News reports - TradingView
TradingViewarrow_outwardAmong them, ABL Bio, a company specializing in antibodies, will participate in the "Alzheimer's Asso.. - 매일경제
매일경제arrow_outwardABL Bio to Introduce ‘Grabody-B’ at World’s Largest Alzheimer’s Conference - Businesskorea
Businesskoreaarrow_outwardWhat Are Anti-Amyloid Treatments for Alzheimer’s Disease? - Healthline
Healthlinearrow_outwardTrojan Horse: Carrying Alzheimer’s Antibodies Into the Brain - Being Patient
Being Patientarrow_outwardRoche’s Brainshuttle technology promises next generation of amyloid beta mAbs, says GlobalData - Express Pharma
Express Pharmaarrow_outwardTrontinemab: Roche Announces Phase 3 Development Program for the mAb in Adults with Early Alzheimer Disease - Patient Care Online
Patient Care Onlinearrow_outwardAD/PD 2025: Roche's Brainshuttle technology promises next generation of amyloid beta mAbs - Clinical Trials Arena
Clinical Trials Arenaarrow_outwardRoche plans Phase 3 for its latest Alzheimer’s drug attempt after unveiling more early data - Endpoints News
Endpoints Newsarrow_outwardRoche To Start Phase 3 Study For Alzheimer's Prospect This Year After New Data From Phase 2 - Benzinga
Benzingaarrow_outwardRoche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025 - Roche
Rochearrow_outwardRoche plans Phase III Alzheimer's study after Brainshuttle antibody eliminates plaque — safely - FirstWord Pharma
FirstWord Pharmaarrow_outwardRoche shows most Alzheimer's patients below amyloid threshold after 28 weeks - Fierce Biotech
Fierce Biotecharrow_outwardBreakthrough: Roche's New Alzheimer's Treatment Achieves 81% Plaque Reduction - Stock Titan
Stock Titanarrow_outwardMonoclonal antibodies: are they the key to treating Alzheimer’s disease? - Labiotech.eu
Labiotech.euarrow_outwardAlzheimer’s Drugs Eyed by Investors Seeking Obesity-Like Gains - Bloomberg.com
Bloomberg.comarrow_outwardAlzheimer’s drugs eyed as next big obesity-like opportunity - The Boston Globe
The Boston Globearrow_outwardEurope reconsiders Alzheimer’s antibody approval - Chemistry World
Chemistry Worldarrow_outward“Crucial steps towards a cure” – my four take-homes from the Clinical Trials on Alzheimer’s Disease (CTAD) conference - Alzheimer's Research UK
Alzheimer's Research UKarrow_outwardRoche weighs whether speedy approval path is open for latest Alzheimer’s drug - BioPharma Dive
BioPharma Divearrow_outwardRoche’s Antibody Against Alzheimer’s Looks the Best Yet - Barron's
Barron'sarrow_outwardEarly data from Roche’s Alzheimer’s therapy show it’s hitting targets - statnews.com
Statnews.comarrow_outwardRoche Discloses Patient Death in Alzheimer’s Trial - SWI swissinfo.ch
SWI swissinfo.charrow_outwardWhich disease-modifying Alzheimer’s drugs are the most promising? - The Guardian
The Guardianarrow_outwardRoche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential - Yahoo Finance
Yahoo Financearrow_outwardObserved plasma concentrations overlaid on pharmacokinetic model... - researchgate.net
Researchgate.netarrow_outward
Trontinemab close
- 2025-07-29 14:20 event
- 49 sourceslanguage
- 100+ ads_click
- 3 weeks ago schedule